Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 02 1995, 342-347, Vol 33, No. 2
LM Frenkel, LE Wagner 2nd, SM Atwood, TJ Cummins and S Dewhurst
The effectiveness of antiretroviral therapy may be limited by the
development of human immunodeficiency virus type 1 (HIV-1) resistance.
Monitoring for resistance will perhaps allow changes in therapy prior to
deterioration in the patient's clinical or immunologic status. Our
objective was to develop a rapid, specific, and sensitive genotypic assay
for HIV-1 resistance to zidovudine (ZDV) and didanosine (ddI) which is
simple to perform. In our assay the DNA of HIV-1 pol was amplified by PCR
using two sets of nested oligonucleotide primers. Mutations of reverse
transcriptase (RT) encoding amino acids (aa) 74 and 41, 70, and 215 which
have been associated with HIV-1 resistance to ddI and ZDV, respectively,
were detected with a ligase detection reaction (LDR) and indicated
colorimetrically. The RT genotypes of 35 patient specimens (140 codons)
blindly assessed for these mutations were in agreement by PCR-LDR and by
dideoxynucleotide sequencing. To evaluate the limits of the assay, other
specimens with mutations close to the ligation site were evaluated by
PCR-LDR. The assay was sensitive and specific for all specimens except when
mutations occurred within 2 bases on either side of the ligation site. In
summary, this PCR-LDR assay specifically, sensitively, and rapidly detected
pol mutations (RT aa 74, 41, 70, and 215) associated with HIV-1 resistance
to ddI and ZDV.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine
Department of Pediatrics, University of Rochester, New York.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|